Enterococci are members of the gastrointestinal flora and emerged in the 1970s as leading causes of multidrug-resistant hospital acquired infections [@bib1]. Enterococcal colonization may result in asymptomatic bacteriuria but also in overt urinary tract infection (UTI) [@bib2]. Vancomycin-resistant enterococci (VRE), the most important class of drug-resistant enterococci, mainly belong to the species *Enterococcus faecium* and contain *vanA* and/or *vanB* genes [@bib3]. There are four additional vancomycin resistance genes: *vanC*, *vanD*, *vanE* and *vanG* [@bib4], [@bib5]. Detection of VRE is possible with culture or PCR [@bib6]. We investigated UTI-related VRE and their *vanA* and *vanB* content from samples of East Iranian origin.

We obtained 177 isolates from 358 urine specimens of patients with UTI from two hospitals (Amir Al-Momenin and Imam Khomeini) in Zabol, Iran (2013--2014). Diagnostics included Gram staining, catalase production, pyrrolidonyl arylamidase detection and growth on bile-esculin/6.5% NaCl media. Vancomycin susceptibility testing included screening on brain--heart infusion (BHI) agar (Difco, USA) containing 6 μg/mL vancomycin (Sigma, Germany). Teicoplanin susceptibility testing was performed using 30 μg teicoplanin disks on Mueller-Hinton agar (Difco; Mast, UK). Minimum inhibitory concentrations (MICs) were determined by agar dilution on BHI agar [@bib7]. The MIC breakpoint for both vancomycin and teicoplanin resistance was ≥32 μg/mL. Susceptibility to vancomycin (MIC ≤4 μg/mL) and to teicoplanin (MIC ≤8 μg/mL) was according to the Clinical and Laboratory Standards Institute.

DNA was extracted according to Perez-Hernandez *et al.* [@bib8] and used for *vanA* and *vanB* PCR. All enterococci were PCR assayed for *vanA* and *vanB* genes using previously described primers and protocols [@bib9]. Resistant *Enterococcus* spp. strains *E. faecalis* E206 (*vanA* positive) and *E. faecium* E2781 (*vanB* positive) were used as positive controls; *Enterococcus faecalis* ATCC 29212 was used as negative control.

We identified seven different species of *Enterococcus*: *E. raffinosus* 3.3% (*n* = 6), *E. durans* 2.8% (*n* = 5), *E. hirae* 3.9% (*n* = 7), *E. avium* 4.5% (*n* = 8)*, E. mundtii* 10% (*n* = 18), *E.* faecium 27% (*n* = 48), and *E.* faecalis 48% (*n* = 85) (*n* = [Table 1](#tbl1){ref-type="table"}). *E. faecalis* and *E. faecium* accounted for 75% of the isolates. Out of 94 isolates from Amir Al-Momenin hospital, 4 (4.2%) were resistant to vancomycin: *E. raffinosus* (*n* = 1), *E. faecalis* (*n* = 2) and *E. mundtii* (*n* = 1) (see [Fig. 1](#fig1){ref-type="fig"}). Imam Khomeini Hospital showed an even lower resistance rate of 3.6% (*n* = 3), including two *E. raffinosus* and one *E. faecium* strains. The overall vancomycin resistance rate in the two hospitals was 3.9% ([Table 2](#tbl2){ref-type="table"}).

All strains resistant to vancomycin showed an MIC of \>512 μg/mL, while MICs obtained for teicoplanin resistant strains varied. *E. faecium* showed the highest teicoplanin MIC (98 μg/mL). *E. faecalis* (69 μg/mL), *E. mundtii* (60 μg/mL) and *E. raffinosus* (18 μg/mL) showed lower MICs.

Hospital-based VRE endemicity differs between countries, within a country and between different cities or hospitals. Here we show that the enterococcal UTI rate in two Iranian medical centers was relatively high. The VRE incidence, however, was not excessive. We show further evidence for the existence of infectious *vanA*-positive *E. mundtii* in humans beyond the single case previously reported from India [@bib10].
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![Patterns of agarose gel electrophoresis showing PCR amplification products for vancomycin resistant enterococci (VRE) lanes 1: *E. faecalis*; lane 2: *E. mundtii*. Lane M, DNA 100 basepair molecular size marker; C+: positive control; C−: negative control.](gr1){#fig1}

###### 

Frequency of enterococcal species in two hospitals in Zabol, Iran

  Hospital          No. of *Enterococcus* spp.                              
  ----------------- ---------------------------- --- --- --- ---- ---- ---- -----
  Amir Al-Momenin   6                            4   1   6   12   26   46   94
  Imam Khomeini     0                            1   6   2   6    24   39   83
  Total             6                            5   7   8   18   48   85   177

###### 

Distribution and VRE species diversity in two hospitals in Zabol, Iran

  Hospital          No. of isolates   VRE species, *n* (%)   No. of *Enterococcus* spp.           
  ----------------- ----------------- ---------------------- ---------------------------- --- --- ---
  Amir Al-Momenin   94                4 (4.2)                1                            0   2   1
  Imam Khomeini     83                3 (3.6)                2                            1   0   0
  Total             177               7 (3.9)                3                            1   2   1

VRE, vancomycin-resistant enterococci.
